Baird Maintains Neutral on Medpace Holdings, Raises Price Target to $624
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
Baird analyst Eric Coldwell maintains Medpace Holdings (NASDAQ:MEDP) with a Neutral and raises the price target from $547 to $624.
Baird analyst Eric Coldwell maintains Medpace Holdings (NASDAQ:MEDP) with a Neutral and raises the price target from $547 to $624.